TRA CỨU
thông tin biểu ghi
  • Bài trích
  • Ký hiệu PL/XG: 615
    Nhan đề: Nghiên cứu dược động học và đánh giá tương đương sinh học viên nén bao phim Losartan Kali 100 mg sản xuất tại Việt Nam /
DDC 615
Tác giả CN Tạ, Mạnh Hùng
Nhan đề Nghiên cứu dược động học và đánh giá tương đương sinh học viên nén bao phim Losartan Kali 100 mg sản xuất tại Việt Nam / Tạ Mạnh Hùng, Đoàn Cao Sơn, Lê Thị Thu Huyền, Trần Hoàng, Phan Thị Nghĩa, Hà Thị Tuyển
Tóm tắt The pharmacokinetics and bioequivalence of the two preparations of Losartan 100 mg tablets were evaluated by a two-way cross-over randomized study. The study involved 24 Vietnamese healthy volunteers taking a single oral dose. Losartan and its main active metabolite in the human plasma samples collected at given intervals of time after administration (0-36h) were assayed by high performance liquid chromatography (HPLC) with positive turbo ion spray ionization tandem mass spectrometry detection (HPLC-MS). The observed pharmacokinetic parameters including area under the curve total (AUCt) and to infinity (AUCinf), peak plasma concentration (Cmax), time to attain peak (Tmax), and elimination half-life (t1/2) were determined and analyzed statistically. Statistically, no significant differences were recored in Cmax and AUC of both losartan and its active metabolite. In the bioequivalence range of 0.8 - 1.25 confidence limits calculated for AUC and Cmax of losartan and its metabolitere were 90 % and 95 %, respectively. These finding confirmed the tested formulation to be well bioequivalent to the reference with respect to losartan and its main active metabolite.
Thuật ngữ chủ đề Nghiên cứu kỹ thuật--Việt Nam
Từ khóa tự do Dược động học
Từ khóa tự do Losartan Kali
Tác giả(bs) CN Đoàn, Cao Sơn
Nguồn trích Tạp chí Dược học 2018tr. 10-13 Số: 12
000 00000nab#a2200000ui#4500
00118607
0029
004856DE92D-EB71-46FE-A831-1EFDF9DF15CD
005202011031532
008081223s vm| vie
0091 0
039|a20201103153208|btainguyendientu|y20191204141122|zthienvan
082 |a615
100 |aTạ, Mạnh Hùng
245 |aNghiên cứu dược động học và đánh giá tương đương sinh học viên nén bao phim Losartan Kali 100 mg sản xuất tại Việt Nam / |cTạ Mạnh Hùng, Đoàn Cao Sơn, Lê Thị Thu Huyền, Trần Hoàng, Phan Thị Nghĩa, Hà Thị Tuyển
520 |aThe pharmacokinetics and bioequivalence of the two preparations of Losartan 100 mg tablets were evaluated by a two-way cross-over randomized study. The study involved 24 Vietnamese healthy volunteers taking a single oral dose. Losartan and its main active metabolite in the human plasma samples collected at given intervals of time after administration (0-36h) were assayed by high performance liquid chromatography (HPLC) with positive turbo ion spray ionization tandem mass spectrometry detection (HPLC-MS). The observed pharmacokinetic parameters including area under the curve total (AUCt) and to infinity (AUCinf), peak plasma concentration (Cmax), time to attain peak (Tmax), and elimination half-life (t1/2) were determined and analyzed statistically. Statistically, no significant differences were recored in Cmax and AUC of both losartan and its active metabolite. In the bioequivalence range of 0.8 - 1.25 confidence limits calculated for AUC and Cmax of losartan and its metabolitere were 90 % and 95 %, respectively. These finding confirmed the tested formulation to be well bioequivalent to the reference with respect to losartan and its main active metabolite.
650 |aNghiên cứu kỹ thuật|zViệt Nam
653 |aDược động học
653 |aLosartan Kali
700 |aĐoàn, Cao Sơn
773 |tTạp chí Dược học |d2018|gtr. 10-13|i12
890|c1|a0|b0|d11
Không tìm thấy biểu ghi nào